A decade after predictions that AI would make radiologists obsolete, demand and salaries for the profession have risen sharply, fueled by growing imaging needs and new AI tools that assist rather than ...
Abbott (NYSE:ABT) announced today that it received FDA clearance and CE mark for its next-generation Ultreon 3.0 software.
Earlier this week, Abbott received U.S. FDA clearance and CE Mark for Ultreon 3.0, an AI-powered optical coherence tomography ...
The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first ...
Abbott receives US FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform: Abbott Park, Illinois Thursday, April 30, 2026, 14:00 Hrs [IST] ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Sharjah: Al Qassimi Hospital in Sharjah, part of Emirates Health Services (EHS), has announced the launch of the latest coronary angiography programme, Ultreon 3.0, a fourth‑generation, ...
Abbott has received both FDA clearance and CE mark for its Ultreon 3.0 software, an AI-powered optical coherence tomography platform for coronary imaging. The system provides real-time guidance during ...
CHENNAI: Kauvery Heart Institute, the centre of excellence in comprehensive cardiac services at Kauvery Hospital – Kovilambakkam, announces the launch of the latest AI-based Ultreon Coronary Imaging ...
Chennai (Tamil Nadu) [India], August 24: Kauvery HospitalAlwarpet, a leading multispecialty healthcare chain in Tamil Nadu, launched an AI based Ultreon OCT-ACR system, which helps in performing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results